Correlation Between Oncternal Therapeutics and Arch Capital

Can any of the company-specific risk be diversified away by investing in both Oncternal Therapeutics and Arch Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncternal Therapeutics and Arch Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncternal Therapeutics and Arch Capital Group, you can compare the effects of market volatilities on Oncternal Therapeutics and Arch Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncternal Therapeutics with a short position of Arch Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncternal Therapeutics and Arch Capital.

Diversification Opportunities for Oncternal Therapeutics and Arch Capital

-0.4

Correlation Coefficient

Oncternal Therapeutics  Arch Capital

Very good diversification

The 3 months correlation between Oncternal and Arch is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Oncternal Therapeutics and Arch Capital Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Capital Group and Oncternal Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncternal Therapeutics are associated (or correlated) with Arch Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Capital Group has no effect on the direction of Oncternal Therapeutics i.e., Oncternal Therapeutics and Arch Capital go up and down completely randomly.

Pair Corralation between Oncternal Therapeutics and Arch Capital

Given the investment horizon of 90 days Oncternal Therapeutics is expected to generate 4.63 times less return on investment than Arch Capital. In addition to that, Oncternal Therapeutics is 2.12 times more volatile than Arch Capital Group. It trades about 0.02 of its total potential returns per unit of risk. Arch Capital Group is currently generating about 0.22 per unit of volatility. If you would invest  9,385  in Arch Capital Group on February 21, 2024 and sell it today you would earn a total of  632.00  from holding Arch Capital Group or generate 6.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Oncternal Therapeutics  vs.  Arch Capital Group

Oncternal Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncternal Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Oncternal Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Arch Capital Group

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Arch Capital Group are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile technical and fundamental indicators, Arch Capital disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oncternal Therapeutics and Arch Capital

The main advantage of trading using opposite Oncternal Therapeutics and Arch Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncternal Therapeutics position performs unexpectedly, Arch Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Capital will offset losses from the drop in Arch Capital's long position.

The idea behind Oncternal Therapeutics and Arch Capital Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.